![](https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/b0192e26d4c674d5b8697bca83206e57.jpg)
New research seems to show the potential of a CRISPR-based gene therapy meant to neuter certain forms of cardiovascular disease. In the world’s first human trial of the therapy, people given the highest doses experienced significant and long-lasting reductions in their low-density lipoprotein cholesterol (LDL-C). The…